62
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center

, , , , , , , , & show all
Pages 6121-6127 | Published online: 22 Nov 2018

References

  • TryggvasonGGíslasonHGMagnússonMKJónassonJGGastrointestinal stromal tumors in Iceland, 1990–2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification studyInt J Cancer2005117228929315900576
  • ChanKHChanCWChowWHGastrointestinal stromal tumors in a cohort of Chinese patients in Hong KongWorld J Gastroenterol200612142223222816610025
  • DematteoRPLewisJJLeungDMudanSSWoodruffJMBrennanMFTwo hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survivalAnn Surg20002311515810636102
  • NilssonBBümmingPMeis-KindblomJMGastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era – a population-based study in western SwedenCancer2005103482182915648083
  • DemetriGDvon MehrenMBlankeCDEfficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumorsN Engl J Med2002347747248012181401
  • VerweijJCasaliPGZalcbergJProgression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialLancet200436494401127113415451219
  • RautCPPosnerMDesaiJSurgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsJ Clin Oncol200624152325233116710031
  • HasegawaJKandaTHirotaSSurgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapyInt J Clin Oncol200712321221717566845
  • AnHJRyuMHRyooBYThe effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GISTAnn Surg Oncol201320134212421824052319
  • BauerSRutkowskiPHohenbergerPLong-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib – analysis of prognostic factors (EORTC-STBSG collaborative study)Eur J Surg Oncol201440441241924491288
  • SeesingMFTielenRvan HillegersbergRResection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective studyEur J Surg Oncol20164291407141327038995
  • ShiYNLiYWangLPGastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North ChinaMedicine20179646e824029145240
  • SatoSTsujinakaTYamamotoKPrimary surgery as a frontline treatment for synchronous metastatic gastrointestinal stromal tumors: an analysis of the Kinki GIST registrySurg Today20164691068107526611538
  • LieglBKeptenILeCHeterogeneity of kinase inhibitor resistance mechanisms in GISTJ Pathol20082161647418623623
  • YehCNChenTWTsengJHSurgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatmentJ Surg Oncol2010102659960320976730
  • DematteoRPBallmanKVAntonescuCRAdjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trialLancet200937396691097110419303137
  • JungJHWonHJShinYMKimPNSafety and Efficacy of Radiofrequency Ablation for Hepatic Metastases from Gastrointestinal Stromal TumorJ Vasc Interv Radiol201526121797180226603498
  • YoonISShinJHHanKUltrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal TumorsKorean J Radiol2018191546229354000
  • KandaTMasuzawaTHiraiTSurgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GISTJpn J Clin Oncol201747436937228073945
  • BlankeCDDemetriGDvon MehrenMLong-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KITJ Clin Oncol200826462062518235121
  • BlayJYPérolDLe CesneAImatinib rechallenge in patients with advanced gastrointestinal stromal tumorsAnn Oncol20122371659166522357253
  • JoensuuHRisk stratification of patients diagnosed with gastrointestinal stromal tumorHum Pathol200839101411141918774375
  • TherassePArbuckSGEisenhauerEANew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst200092320521610655437